Trulicity is not approved as a weight loss drug, but some people may lose weight while using it
Tirzepatide (Mounjaro/Zepbound): Activates both GLP-1 and GIP receptors, offering enhanced metabolic benefits and potentially greater weight loss
Wegovy offers the assurance of a brand-name, FDA-approved product, while compounded semaglutide offers a flexible and available alternative for those facing shortages or requiring personalized dosing
Whether this pattern persists beyond 52 weeks, whether it is dose-dependent, and whether it is reversible upon discontinuation of therapy are questions that remain unanswered and need to be addressed in larger, longer-duration trials
At $25 per month, resM is the most accessible option in the GLP-1-related product space, though you get what you pay for in terms of effect magnitude
It contains antioxidants and anti-inflammatory compounds that can help soothe digestive issues, reduce bloating, and improve appetite